A Guide to Federal Food Labeling Requirements for Meat and Poultry Products
fsis.usda.gov - 656.92 KB - 117 page(s)

by FSIS. Answers to the most commonly asked questions are incorporated. This Guide cannot possibly anticipate or address the large number of issues that may arise in developing product labeling. The federal regulatory agencies that have jurisdiction over food products derive their authority to govern the labeling of these products from several principal statutes -- the Federal Meat Inspection Act (FMIA), ...

Tag Icon guide federal labeling requirements poultry products
Introduction to Clinical Research
pbi.org - 188.08 KB - 52 page(s)

University of Pennsylvania Philadelphia, PA March 13, 2012 OVERVIEW OF CLINICAL RESEARCH: A Brief History > Early attempts to regulate pharmaceuticals were rudimentary – Prior to 1938, applicable federal law consisted of the Pure Food and Drug Act of 1906 and the Harrison Act of 1914, which prohibited the sale of certain narcotics – Sadly, improvements to the regulatory framework would come in response ...

Tag Icon introduction clinical research
Determination of Cobalamin in Chlorella Food by Cation Exchange Column and Graphite Furnace Atomic Absorption Spectrometry
fda.gov.tw - 256.99 KB - 4 page(s)

graphite furnace AAS -- 10 g/L (Merck, Darmstadt, Germany). (VII) Magnesium nitrate hexahydrate (Suprapur, Merck, Darmstadt, Germany). III. Sample Preparation Chlorella food (tablet or powder) was homogenized and weighed accurately (ca 1.0 g) in a plastic centrifuge tube. After 30 mL of water was added, extraction was carried out in ...

Tag Icon determination cobalamin chlorella cation exchange column graphite furnace atomic absorption spectrometry
Guidance for Industry Applications Covered by Section 505(b)(2)
fda.gov - 41.41 KB - 15 page(s)

This guidance identifies the types of applications that are covered by section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (the Act). A 505(b)(2) application is a new drug application (NDA) described in section 505(b)(2) of the Act. It is submitted under section 505(b)(1) of the Act and approved ...

Tag Icon guidance industry applications covered section
Qualification Process for Drug Development Tools
fda.gov - 189.56 KB - 22 page(s)

DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should be submitted within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, ...

Tag Icon qualification process development tools
From Pharmacovigilance to Pharmacovigilance Planning-The System Building for Safe Medication
fda.gov.tw - 491.72 KB - 10 page(s)

International Organizations of Medical Sciences (CIOMS) and ICH developed and published Topic ICH E2E Guideline in 2005 as an action of implementing PVP(4). It reflected a proactive thinking of the system building for safe medication. It also led to the emerging strategies for r isk-management in the European Union, the ...

Tag Icon pharmacovigilance planning system building medication
DRUG TESTING A BAD INVESTMENT
aclu.org - 216 KB - 29 page(s)

other rehabilitative services are offered to drug-positive workers, the price tag of a drug testing I n 1986, President Ronald Reagan issued program increases further. an Executive Order requiring federal agencies to institute urine testing pro- grams for the purpose of creating “drug-free federal workplaces.”1 In the years since, Surprisingly Few Employers Have Evaluated the Effectiveness of Their Drug ...

Tag Icon testing investment
2011 Update of the Drug Resistance Mutations in HIV-1
iasusa.org - 802.04 KB - 9 page(s)

K 65 R M 184 V I Lamivudine K 65 R K 219 Q E L 74 V Emtricitabine K 219 Q E LT 210 215 WY F Abacavirf,g K 219 Q E M 184 V I Stavudined,e,g,i,j,k Tenofovirl Zidovudined,e,j,k M 41 L KD 65 67 RN K 70 R ...

Tag Icon update resistance mutations
Controlled Substances Security Manual
deadiversion.usdoj.gov - 106.79 KB - 30 page(s)

of 1970 Revised May 1991 2 A MESSAGE FROM THE ADMINISTRATOR The safeguarding of controlled substances is a problem confronting all manufacturers, distributors, pharmacies, and other drug handlers. Federal law limits the handling of these substances and by regulation requires that they be properly safeguarded at all times. The drug Enforcement Administration (DEA) is responsible for ensuring that effective ...

Tag Icon controlled substances security manual
Urine Drug Testing in Clinical Practice
familydocs.org - 1.19 MB - 24 page(s)

URINE DRUG TESTING METHODS 3 Immunoassays 3 Laboratory-Based Specific Drug Identification 3 Drug-Class–Specific Windows of Detection 3 Characteristics of Urine 4 CURRENT USES OF URINE DRUG TESTING 5 Federally Regulated Testing 5 Nonregulated Forensic Testing 5 Patient-Centered Clinical Urine Drug Testing 5 IMPROVING RELIABILITY OF PATIENT-CENTERED CLINICAL TESTING 6 Why to Test 6 Whom to Test 7 When to Test ...

Tag Icon urine testing clinical practice